VASHISHT GOPAL YENNU NANDA
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oxidative Phosphorylation | 2 | 2019 | 253 | 0.540 |
Why?
|
| Proto-Oncogene Proteins B-raf | 6 | 2019 | 1283 | 0.500 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 848 | 0.450 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2014 | 1678 | 0.440 |
Why?
|
| Histone Deacetylases | 4 | 2009 | 365 | 0.400 |
Why?
|
| Topoisomerase II Inhibitors | 4 | 2002 | 58 | 0.380 |
Why?
|
| Melanoma | 6 | 2019 | 5317 | 0.350 |
Why?
|
| Organometallic Compounds | 4 | 2002 | 191 | 0.350 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2019 | 1546 | 0.340 |
Why?
|
| Sesquiterpenes | 2 | 2009 | 68 | 0.320 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2019 | 4757 | 0.300 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2014 | 639 | 0.250 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2019 | 5178 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2007 | 1538 | 0.210 |
Why?
|
| DNA | 6 | 2007 | 2693 | 0.210 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 395 | 0.210 |
Why?
|
| Ruthenium Compounds | 2 | 2001 | 3 | 0.190 |
Why?
|
| Signal Transduction | 5 | 2014 | 11965 | 0.180 |
Why?
|
| Indoles | 2 | 2012 | 1009 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2014 | 2054 | 0.180 |
Why?
|
| DNA Topoisomerases, Type II | 4 | 2002 | 116 | 0.160 |
Why?
|
| I-kappa B Kinase | 2 | 2006 | 250 | 0.160 |
Why?
|
| Benzimidazoles | 1 | 2010 | 428 | 0.150 |
Why?
|
| Sulfonamides | 2 | 2012 | 1823 | 0.140 |
Why?
|
| Ubiquitination | 1 | 2009 | 575 | 0.140 |
Why?
|
| Antineoplastic Agents | 8 | 2012 | 14289 | 0.140 |
Why?
|
| Colonic Neoplasms | 2 | 2012 | 1390 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2009 | 507 | 0.130 |
Why?
|
| Bronchi | 1 | 2007 | 326 | 0.130 |
Why?
|
| Cell Line, Tumor | 8 | 2019 | 14551 | 0.130 |
Why?
|
| Cell Death | 1 | 2007 | 671 | 0.130 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 5112 | 0.120 |
Why?
|
| Nylons | 1 | 2003 | 19 | 0.120 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2003 | 37 | 0.120 |
Why?
|
| Enzyme Inhibitors | 2 | 2002 | 1879 | 0.120 |
Why?
|
| Histone Deacetylase 1 | 3 | 2009 | 62 | 0.110 |
Why?
|
| Dimethyl Sulfoxide | 2 | 2002 | 52 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2009 | 3552 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 2330 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 8873 | 0.100 |
Why?
|
| Phosphatidic Acids | 1 | 2010 | 16 | 0.100 |
Why?
|
| Imidazoles | 2 | 2009 | 999 | 0.090 |
Why?
|
| Ferrous Compounds | 1 | 2000 | 13 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2007 | 1549 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2007 | 1818 | 0.090 |
Why?
|
| Indazoles | 1 | 2001 | 297 | 0.090 |
Why?
|
| Oxadiazoles | 1 | 2019 | 57 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 1823 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 460 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 5 | 2010 | 5395 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 2045 | 0.080 |
Why?
|
| Oximes | 1 | 1999 | 175 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2012 | 7226 | 0.080 |
Why?
|
| Melanoma, Experimental | 1 | 2010 | 368 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2006 | 4053 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 479 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 4849 | 0.070 |
Why?
|
| Heterografts | 1 | 2019 | 733 | 0.070 |
Why?
|
| Inflammation | 1 | 2006 | 2522 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2007 | 4821 | 0.070 |
Why?
|
| Point Mutation | 1 | 2009 | 769 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2012 | 986 | 0.070 |
Why?
|
| Apoptosis | 1 | 2010 | 7591 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 3639 | 0.070 |
Why?
|
| RNA, Small Interfering | 3 | 2010 | 2216 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2012 | 3536 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2007 | 528 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2019 | 874 | 0.060 |
Why?
|
| Thiazoles | 1 | 2009 | 726 | 0.060 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2014 | 42 | 0.060 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2014 | 68 | 0.060 |
Why?
|
| Animals | 10 | 2019 | 59536 | 0.060 |
Why?
|
| Cell Survival | 3 | 2012 | 3045 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2007 | 589 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 4654 | 0.060 |
Why?
|
| Piperidines | 1 | 2019 | 1035 | 0.060 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 265 | 0.060 |
Why?
|
| Adenosine Triphosphatases | 3 | 2001 | 435 | 0.060 |
Why?
|
| Mice | 5 | 2019 | 34495 | 0.050 |
Why?
|
| Binding Sites | 3 | 2003 | 2171 | 0.050 |
Why?
|
| Humans | 16 | 2019 | 261506 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2014 | 6150 | 0.050 |
Why?
|
| Mitochondria | 1 | 2019 | 1282 | 0.050 |
Why?
|
| Cell Division | 3 | 2002 | 2489 | 0.050 |
Why?
|
| Gonanes | 1 | 2012 | 45 | 0.050 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 336 | 0.050 |
Why?
|
| Rats | 4 | 2002 | 6086 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 2 | 2003 | 279 | 0.050 |
Why?
|
| Methylation | 1 | 2012 | 597 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 149 | 0.050 |
Why?
|
| Thymidine | 2 | 2001 | 155 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 2173 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2010 | 86 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2012 | 566 | 0.050 |
Why?
|
| Liver | 1 | 1999 | 2961 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2007 | 5319 | 0.040 |
Why?
|
| Thermodynamics | 2 | 2000 | 196 | 0.040 |
Why?
|
| Molecular Structure | 2 | 2001 | 515 | 0.040 |
Why?
|
| Transfection | 2 | 2010 | 2944 | 0.040 |
Why?
|
| Ligands | 2 | 2003 | 995 | 0.040 |
Why?
|
| Mutation | 3 | 2014 | 15179 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2009 | 348 | 0.040 |
Why?
|
| Sirolimus | 1 | 2012 | 814 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 1516 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2007 | 227 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2009 | 3518 | 0.040 |
Why?
|
| Azacitidine | 1 | 2012 | 1149 | 0.040 |
Why?
|
| Acetylation | 1 | 2007 | 508 | 0.030 |
Why?
|
| Piperazines | 2 | 2009 | 2101 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2007 | 430 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2005 | 205 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2007 | 652 | 0.030 |
Why?
|
| Base Sequence | 2 | 2009 | 4917 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2006 | 344 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 803 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 2005 | 461 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 11538 | 0.030 |
Why?
|
| DNA Footprinting | 1 | 2003 | 34 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 1 | 2003 | 117 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2012 | 4804 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 2003 | 117 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2014 | 2819 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2005 | 558 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 621 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2003 | 261 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2003 | 336 | 0.030 |
Why?
|
| Intercalating Agents | 1 | 2002 | 29 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2009 | 2450 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2003 | 549 | 0.030 |
Why?
|
| Protein Binding | 1 | 2009 | 3438 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2007 | 1620 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 931 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 1073 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 3154 | 0.020 |
Why?
|
| Phosphodiesterase I | 1 | 2010 | 20 | 0.020 |
Why?
|
| Metallocenes | 1 | 2000 | 3 | 0.020 |
Why?
|
| Brain | 1 | 2014 | 4113 | 0.020 |
Why?
|
| Pyrophosphatases | 1 | 2010 | 51 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 5270 | 0.020 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2010 | 80 | 0.020 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2010 | 103 | 0.020 |
Why?
|
| Models, Biological | 1 | 2009 | 3254 | 0.020 |
Why?
|
| Histones | 1 | 2007 | 1466 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 7222 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 1618 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 1999 | 105 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2010 | 213 | 0.020 |
Why?
|
| DNA Ligases | 1 | 1999 | 63 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 1999 | 149 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1999 | 293 | 0.020 |
Why?
|
| Catalysis | 1 | 1999 | 250 | 0.020 |
Why?
|
| Cattle | 1 | 2000 | 783 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1999 | 553 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2005 | 5637 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 1910 | 0.020 |
Why?
|
| Kinetics | 1 | 1999 | 2049 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 6089 | 0.020 |
Why?
|
| Dasatinib | 1 | 2009 | 862 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 1999 | 1764 | 0.020 |
Why?
|
| Imatinib Mesylate | 1 | 2009 | 1665 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 5159 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2009 | 1732 | 0.020 |
Why?
|
| DNA Damage | 1 | 2002 | 1954 | 0.010 |
Why?
|
| Benzamides | 1 | 2009 | 1832 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 12926 | 0.010 |
Why?
|
| Gene Expression | 1 | 2010 | 3570 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 3821 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 15862 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 15694 | 0.000 |
Why?
|
| Female | 1 | 2002 | 141928 | 0.000 |
Why?
|